Business Standard

RML Hospital's resident doctors association apprehensive about Covaxin

With one hour to go before the vaccination process ended, only 31 people had taken the jab

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma
Premium

Bharat Biotech's Covaxin is still in Phase 3 trials | Representational image

Geetika SrivastavaNitin Kumar New Delhi
The Ram Manohar Lohia Hospital's (RMLH's) Resident Doctor Association (RDA) has officially sent a letter to the hospital administration, saying doctors of the hospital are apprehensive about Bharat Biotech's Covaxin, which is the only vaccine being used at the vaccination centre.

With only one hour to go before end of Day 1, only 31 people had turned up to receive the Covaxin jab at the hospital, according to Dr. Palak, medical officer at vaccine site number 2 of the hospital. “We hope more people will come out for vaccination soon,” she added. 

 “As of now, we can only take Covaxin, otherwise no

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in